Who owns CRISPR Therapeutics AG (CRSP)? Elite investor 13F holders
3 tracked elite investors reported holding CRISPR Therapeutics AG as of 2026-06-30, including D.E. Shaw, Tudor Investment, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | CRISPR THERAPEUTICS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 48748506.00 USD | 893812.000000 | Shares | buy | Original filing |
| Tudor Investment | CRISPR THERAPEUTICS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2318604.00 USD | 42512.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | CRISPR THERAPEUTICS AG | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 217669.00 USD | 3991.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.